Gumalam, Baby Girl .
HRN: 28-84-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/15/2026
04/22/2026
IVTT
46mg
Q24h
PSNB
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: